May 11, 2018 / 8:36 PM / 16 days ago

BRIEF-U.S. FDA expands approval of Gilenya to treat multile sclerosis in children

May 11 (Reuters) - Novartis AG:

* U.S. FDA SAYS APPROVED GILENYA (FINGOLIMOD) TO TREAT RELAPSING MULTIPLE SCLEROSIS IN CHILDREN & ADOLESCENTS AGE 10 YRS & OLDER

* U.S. FDA SAYS GRANTED THE APPROVAL OF GILENYA TO NOVARTIS Source text: (reut.rs/2rD6Tej) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below